12 / 13
Page 34
allied
academies
J Nutr Hum Health 2017 Volume 1 Issue 2
Notes:
July 24-26, 2017 | Vancouver, Canada
International conference on
DIABETES, NUTRITION, METABOLISM & MEDICARE
P
atients with insulin-dependent diabetes mellitus (IDDM)
show low adherence to insulin injections, which results in
poor glycemic control. i-port advance provides a comfortable
yet dependable way to inject insulin that allows patients to
take multiple daily subcutaneous injections for three days
without having to puncture skin for each dose of insulin. Our
aim is to evaluate patient satisfaction, glycemic control, and
adherence while using this device.
Methods:
This prospective study examined IDDM patients.
Baseline characteristics and diabetes treatment satisfaction
questionnaire status (DTSQs) were collected at baseline and
at the end of the follow up. All patients were trained to use
the i-Port. We divided them into two groups: regular users of
the i-Port who used it for >3 months, and irregular users who
used it for <3 months. The local complications during use of
the i-Port were recorded.
Results & Discussion:
Of the total of 55 patients, 92.7%
had type I diabetes, the mean age was 14.96+8.95, 92.7%
were used an insulin pen. The patients were divided into
27 regular users and 28 irregular users. Irregular users
had a longer duration of DM (p=0.901) at baseline and
compared to the regular users, and they were less likely to
report non-compliance with insulin usage (p=0.338), more
likely to self-inject insulin (p=0.038), and had lower HbA1c
(p=0.056). There was no statistical difference in the mean
DTSQs score or the mean glycemic control score between
groups. At the end of the follow up, the regular i-port usage
improved compliance with insulin usage (p=0.028), reduced
diabetes-related hospitalization (p <0.001), and reduced the
frequency of hypoglycemia (p=0.184). Scarring at i-port site
was the most common complication.
Conclusion:
Regular i-Port usage improved compliance and
decreased hospitalization and hypoglycemic episodes with a
non-significant 0.73% reduction in HbA1c.
Biography
Amal M Khan has completed her Bachelor of Medicine Bachelor of Surgery (MBBS) at
College of Medicine, Taif University, Taif, KSA. She is an amateur writer, enthusiastic,
patient and hard worker Medical Intern. She adores the scientific research and she
will contentious the education in Family Medicine Residency program. She was a
speaker at local and international conferences and was Best Young Researchers for oral
presentation at the 14th international conference and exhibition on targeting diabetes
and novel therapeutic, Malaysia. She has published a lot of researches in a field of
diabetes. She has attended and participated at a lot of conference and workshop in
endocrinology and medical field
dr.amal-khan@msn.comThe benefits of using the I-port system on insulin-dependent patients
Amal M Khan
and
Khaled A Alswat
Taif University, Saudi Arabia